New Management Strategies of Hormone Refractory Prostate Cancer (HRPC)

Carcinoma prostate is the commonest cancer in men and recognized as the commonest killer of men. prostate cancer incidence is increasing in bangladesh as the detection technology and people are servings longer. prostate cancer progression ends up at hormone refractory prostate cancer (hrpc) or stage d3 status where no endocrine manipulation is effective. the median survival at this stage of prostate cancer is usually less than 10 months. world wide life of the most of the prostate cancer patients are terminated at this stage.